Skip to NavigationSkip to content

News

The approval specifically relates to the treatment of life-threatening or uncontrolled bleeding in adult patients treated with the direct Factor Xa...
“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated,...
England is set to increase lockdown restrictions across the country after a surge in coronavirus cases.
The company is testing higher doses of Ocrevus against both relapsing MS and primary progressive MS while also studying the treatment in minority...
The companies involved include AstraZeneca, Moderna, Pfizer, Sanofi, GlaxoSmithKline, BioNTech, Novavax, Johnson & Johnson and MSD.
The portfolio of products, sold primarily in Europe and Canada, include therapies in the anti-inflammatory and cardiovascular/metabolic spaces...
"Patients on Dupixent maintained asthma control and reduced rates of severe asthma attacks that may result in hospitalisations."
Mylan has announced an agreement to acquire the intellectual property and commercialisation rights to Aspen’s thrombosis business for €641.9 million.
Hundreds of thousands of people in China have been inoculated with two experimental vaccines on an emergency use scheme, according to a state-owned...
60,000 people across Britain may have been suffering from prolonged symptoms of coronavirus months after contracting the virus.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches